Medication info
Valtan Plus Tablet 160/12.5 mg

Valtan Plus Tablet 160/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Dark red oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200807284 · Notified 2008.07.01 · Insurance code 645903750

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when prescribed as valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or more). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for essential hypertension (primary hypertension) that is not adequately controlled with monotherapy.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg applies when prescribed as valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or more). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately upon confirmation of pregnancy. It should not be used in case of hypersensitivity to any of its components or similar drugs. This medication should not be administered to patients with severe liver or kidney impairment, and regular checks are needed in cases of mild kidney impairment. This medication can cause electrolyte imbalances, so potassium, sodium, and other blood concentrations should be checked regularly, and potassium supplements should not be taken without a doctor's instructions. Dizziness or drowsiness may occur, so caution is needed when driving or operating machinery. There may be an increased risk of skin cancer while taking this medication, so exposure to sunlight or ultraviolet light should be limited, and any skin changes should be reported to a healthcare professional immediately. As this medication can interact with other drugs, especially lithium, non-steroidal anti-inflammatory drugs (NSAIDs), and potassium-sparing diuretics, consult a doctor when taken concurrently. In case of overdose, symptoms such as hypotension, arrhythmia, or electrolyte disturbances may occur, and immediate medical attention is necessary if this happens. Safety and efficacy in pediatric patients have not been established, so it is best not to administer this medication to them. For the elderly, while there are no significant differences in effects and side effects, caution is advised in administration. This medication should be stored in a cool place out of reach of children, avoiding moisture and direct sunlight, and it is important to keep it in its original container.

Side effects

headache, dizziness, pharyngitis, fatigue, back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, gastroenteritis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle spasms, myositis, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngeal pain, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney damage, myalgia, anaphylactoid symptoms, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, edema, weakness, hypertriglyceridemia, increased creatine kinase, decreased hemoglobin, thrombocytopenia, increased serum potassium, hyponatremia, dizziness, vasculitis, elevated liver function tests, angioedema, rash, vesicular dermatitis, renal failure, hypokalemia, increased blood lipids, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic metabolic alkalosis, hyperglycemia, diabetes, decreased appetite, nausea, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmias, sensory loss, sedation, headache, sleep disturbances, depression, paresthesia, visual impairment, thrombocytopenia, leukopenia, agranulocytosis, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, hypersensitivity reaction, pneumonia, pulmonary edema, acute renal failure, kidney injury, aplastic anemia, erythema multiforme, fever, muscle spasms, weakness, acute closed-angle glaucoma, choroidal exudate, dizziness, drowsiness, symptomatic hypotension, hypotension, tachycardia, nausea, drowsiness, hypovolemia, arrhythmia, muscle rigidity

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be kept in a tightly sealed container. Additionally, it should be stored in a cool place below 30 degrees Celsius for optimal efficacy.

Appearance and packaging

Appearance

Dark red oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.